The landscape of diabetes management is continually evolving, presenting innovative therapies that offer improved efficacy and patient experience. Among these advancements, tirzepatide has emerged as a promising treatment option, demonstrating remarkable results in clinical trials. As a dual GLP-1 and GIP receptor agonist, tirzepatide modulates bot